A 2015 Cochrane databases critique identified insufficient evidence to justify using G. lucidum as a first-line cancer treatment method.[five][6] It stated that G. lucidum may have "gain instead adjunct to conventional remedy in consideration of its opportunity of improving tumour response and stimulating host immunity. Most of the proposed benefits https://mariopaidt.thekatyblog.com/31371189/brain-health-supplements-an-overview